In less than three years since its home debut, Shenzhen Mindray Bio-Medical Electronics has handed stock investors greater returns than all the largest companies traded on the Shanghai and Shenzhen ...

Mindray ($MR) is in trouble with the FDA over manufacturing problems with the company's patient monitors and other medical equipment. Regulators cited China's largest ...

Revolutionizing radiology with cutting-edge imaging, smart automation, and effortless control — the Resona A20 is built to elevate diagnostic confidence like never before. Ultra Precise - Advanced ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Mindray Medical ($MR) and Masimo ($MASI) are laying their years-long legal battle over pulse oximeter technology to rest, with the companies agreeing to dismiss all ...

BEIJING, May 17 (Reuters) - China's Shenzhen Mindray Bio-Medical Electronics (300760.SZ), opens new tab has agreed to acquire HyTest, a supplier of raw materials used in tests for diseases such as ...

BEIJING/HONG KONG, Jan 29 (Reuters) - Chinese medical device company Shenzhen Mindray Bio-Medical Electronics (300760.SZ), opens new tab said it planned a 6.65 billion yuan ($927 million) deal to gain ...

MAHWAH, N.J., Nov. 19, 2025 /PRNewswire/ -- Mindray, a leading global developer of healthcare technologies and solutions specializing in patient monitoring, anesthesia, and ultrasound, continues to ...

When the World Health Organization (WHO) declared the coronavirus outbreak a global pandemic in March 2020, hospital directors in the United States and Europe knew exactly where they should look to ...